Futura Medical (LON:FUM) Stock Price Up 11.7% – Should You Buy?

Futura Medical plc (LON:FUM)’s share price traded up 11.7% on Thursday. The stock traded as high as GBX 0.23 and last traded at GBX 0.22. 17,144,963 shares changed hands during mid-day trading, an increase of 65% from the average session volume of 10,386,199 shares. The stock had previously closed at GBX 0.20.

Futura Medical Price Performance

The firm has a market capitalization of £1.28 million, a price-to-earnings ratio of -0.27 and a beta of 0.02. The stock has a fifty day moving average of GBX 0.33 and a two-hundred day moving average of GBX 0.64.

Futura Medical (LON:FUM) last announced its earnings results on Tuesday, September 1st. The company reported GBX (0.20) EPS for the quarter. Futura Medical had a negative return on equity of 152.42% and a negative net margin of 158.21%. On average, research analysts forecast that Futura Medical plc will post 2.8486672 EPS for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.